Work

Editorial: Comparable Hepatic Fibrosis Risk Demands Equal Vigilance in Lean and Non‐Lean Patients With Metabolic Dysfunction‐Associated Steatotic Liver Disease—Authors' Reply

Year: 2025

Type: editorial

Abstract: fatty liver | genetic risk score | MASLD | NITs

Source: Alimentary Pharmacology & Therapeutics

DOI: 10.1111/apt.70460

Authors: Kaleb Tesfai, Luis Antonio Díaz, Veeral Ajmera

Institutions: University of California San Diego, Pontificia Universidad Católica de Chile

Language: English

Topic: Liver Disease Diagnosis and Treatment

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases

Awards: A Novel Multimodal Approach to Characterize NAFLD Severity and Prognosis, G990665675

OpenAlex ID: W4416129284

Cites: 10

Cited by:

Related to: